A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer
Clinical trial NCT07174063 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07174063
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2027-01-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.